01 Juli 2019

Dr. Stefano Biondi Appointed Head of CMC of BioVersys

BioVersys is strengthening its executive management team with the appointment of Dr. Stefano Biondi as Head of CMC as of July 1st, 2019. He will lead...


08 Apr. 2019

BIOVERSYS IS FEATURED IN A FORBES FRANCE SPECIAL

BioVersys is featured in a Forbes France special presenting 10 Swiss SME's to watch. A link to the English version can be found at the bottom of th...


08 Apr. 2019

ARE NOVEL ANTIBIOTICS WORTH INVESTING IN?


08 Apr. 2019

PRESS RELEASE - NEW CDO AT BIOVERSYS - DR. GLENN DALE

BioVersys is pleased to announce the appointment of Dr. Glenn Dale as Chief Development Officer as of February 1st, 2019.